• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

New Delhi, Nov. 17

Jubilant Organosis has acquired Canada-based TrialStat Clynical Analytics for a consideration of Canadian dollar 7.5 lakh. The acquisition has been made by Jubilant’s New Jersey-based subsidiary, Clinsys Clinical Research Inc, the company said in a release. TrialStat is a web-based electronic data capture (EDC) solution currently used by a wide range of pharmaceutical and contract research organisations globally. TrialStat is the industry’s first platform to al low all aspects of a study to be configured, deployed and managed through a browser interface, enabling customers to start their studies quickly and cost effectively. In a joint statement on the acquisition, the company Chairman and Managing Director, Mr Shyam Bhartia, and the Co-Chairman and Managing Director, Mr Hari Bhartia, said “the addition of TrialStat and its proven EDC offering will allow Clinsys to continue to expand its integrated solutions for pharmaceutical, biotechnology and medical device organisations.”

– Our Bureau

More Stories on : Mergers & Acquisitions | Pharmaceuticals | Overseas Investments

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line